N. Shang

T. Sterling, R. Reves, N. Shang, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Risk factors for community-acquired bacterial infection among young infants in South Asia: a longitudinal cohort study with nested case–control analysis

Maureen H Diaz, S. Schrag, D. Hamer, 2022, BMJ Global Health.

Infectious aetiologies of neonatal illness in south Asia classified using WHO definitions: a primary analysis of the ANISA study

S. Schrag, S. Meshnick, L. Mullany, 2022, Lancet Global Health.

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation

T. Skoff, P. Cieslak, N. Shang, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Impact of the U.S. Maternal Tdap Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-control Evaluation

T. Skoff, P. Cieslak, N. Shang, 2017 .

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

R. Link-Gelles, S. Schrag, R. Wiegand, 2022, MMWR. Morbidity and mortality weekly report.

Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017.

Michael W. Spiller, C. Whitney, F. Lessa, 2022, JAMA internal medicine.

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

K. Castro, T. Moeti, N. Shang, 2011, The Lancet.

Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021

S. Schrag, J. Jernigan, S. Parikh, 2021, MMWR. Morbidity and mortality weekly report.

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 202

R. Link-Gelles, R. Wiegand, N. Shang, 2023, MMWR. Morbidity and mortality weekly report.

Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.

M. Conde, T. Sterling, N. Shang, 2015, JAMA pediatrics.

Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.

T. Sterling, N. Shang, W. M. Mac Kenzie, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study

Maureen H Diaz, S. Schrag, M. Hasanuzzaman, 2018, The Lancet.

Pneumonia Hospitalization Coding Changes Associated With Transition From the 9th to 10th Revision of International Classification of Diseases

F. Lessa, N. Shang, Carlos G. Grijalva, 2020, Health services research and managerial epidemiology.

Pneumonia Hospitalization Coding Changes Associated With Transition From the 9th to 10th Revision of International Classification of Diseases.

F. Lessa, N. Shang, Carlos G. Grijalva, 2020 .

The epidemiology and estimated etiology of pathogens detected from the upper respiratory tract of adults with severe acute respiratory infections in multiple countries, 2014–2015

S. Lindstrom, J. Montgomery, N. Shang, 2020, PloS one.

Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.

R. Link-Gelles, S. Schrag, N. Shang, 2022, JAMA.

Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.

S. Schrag, N. Shang, J. Verani, 2022, JAMA.

Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023

R. Link-Gelles, R. Wiegand, N. Shang, 2023, MMWR. Morbidity and mortality weekly report.

Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021

W. Schaffner, S. Schrag, R. Lynfield, 2021, MMWR. Morbidity and mortality weekly report.

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron

R. Link-Gelles, S. Schrag, N. Shang, 2022, The New England journal of medicine.

Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022

R. Link-Gelles, A. Benin, N. Shang, 2022, MMWR. Morbidity and mortality weekly report.

Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study

W. Schaffner, R. Link-Gelles, C. Whitney, 2016, SSM - population health.

Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USA

W. Schaffner, R. Link-Gelles, C. Whitney, 2017, BMJ Open.

Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada.

T. Sterling, N. Shang, S. Goldberg, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Bayesian analysis of the 2009 decline in tuberculosis morbidity in the United States

N. Shang, C. Winston, J. Becerra, 2012, Statistics in medicine.

Detection of Mycobacterium tuberculosis Infection in United States Navy Recruits Using the Tuberculin Skin Test or Whole-Blood Interferon- g Release Assays

N. Shang, P. Lobue, G. Mazurek, 2007 .

Tuberculosis transmission in nontraditional settings: a decision-tree approach.

J. Kammerer, T. Navin, N. Shang, 2005, American journal of preventive medicine.

Added epidemiologic value to tuberculosis prevention and control of the investigation of clustered genotypes of Mycobacterium tuberculosis isolates.

C. Braden, J. Kammerer, T. Navin, 2004, American journal of epidemiology.

Using Routinely Reported Tuberculosis Genotyping and Surveillance Data to Predict Tuberculosis Outbreaks

S. Althomsons, T. Navin, N. Shang, 2012, PloS one.

Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.

N. Shang, P. Lobue, G. Mazurek, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021

W. Schaffner, S. Schrag, R. Lynfield, 2021, Morbidity and Mortality Weekly Report.

Using statistical methods and genotyping to detect tuberculosis outbreaks

J. Kammerer, S. Althomsons, T. Navin, 2013 .

Three months of rifapentine and isoniazid for latent tuberculosis infection.

J. Hackman, R. Chaisson, M. Conde, 2011, The New England journal of medicine.